Data / Form D filings / AGENUS INC
AGENUS INC: Form D filings
AGENUS INC, a biotechnology company in Lexington, MA, filed 11 Form D notices with the SEC between 2009 and 2019. The latest, on February 1, 2019, reports $30 million sold of a $30 million offering to 1 investor.
Find out what AGENUS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3 Forbes Road, Lexington, MA, 02421
- Phone
- (781) 674-4400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1098972
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 1, 2019 | New notice | $30,000,000 | $30,000,000 | $0 | 1 | Jan 23, 2019 | sec.gov |
| Oct 25, 2018 | New notice | $40,000,653 | $40,000,653 | $0 | 2 | Oct 11, 2018 | sec.gov |
| Mar 1, 2017 | New notice | $60,000,000 | $60,000,000 | $0 | 1 | Feb 14, 2017 | sec.gov |
| Jan 8, 2016 | New notice | $500,000 | $500,000 | $0 | 1 | Dec 31, 2015 | sec.gov |
| Jan 4, 2016 | New notice | $42,400,090 | $7,400,090 | $35,000,000 | 17 | Dec 23, 2015 | sec.gov |
| Sep 23, 2015 | New notice | $2,142,000 | $2,142,000 | $0 | 2 | Sep 8, 2015 | sec.gov |
| Mar 5, 2015 | New notice | $21,140,000 | $21,140,000 | $0 | 8 | Feb 20, 2015 | sec.gov |
| Mar 5, 2015 | New notice | $35,000,000 | $35,000,000 | $0 | 1 | Feb 18, 2015 | sec.gov |
| Apr 25, 2013 | New notice | $5,000,000 | $5,000,000 | $0 | 3 | Apr 15, 2013 | sec.gov |
| Aug 13, 2009 | New notice | $10,000,000 | $10,000,000 | $0 | 4 | Aug 4, 2009 | sec.gov |
| Aug 13, 2009 | New notice | $10,000,000 | $10,000,000 | $0 | 1 | Aug 3, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian H. Corvese | Director | |
| Evan R. Kearns | Executive Officer | |
| Timothy R. Wright | Director | |
| Jennifer R. Buell | Executive Officer | |
| Ulf H. Wiinberg | Director | |
| Ozer R. Baysal | Executive Officer | |
| Wadih H. Jordan | Director | |
| Alex R. Duncan | Executive Officer | |
| Christine R. Klaskin | Executive Officer | |
| Allison R. Jeynes-Ellis | Director | |
| Christian R. Cortis | Executive Officer | |
| Garo H. Armen | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
- Axelyf, Inc. $2.6 million · Oct 13, 2026
- BIOVENTRIX, INC. $1.2 million · Oct 8, 2026
- Opus KSD, Inc. $680,801 · Oct 1, 2026
- Xact Bio, Inc. $10 million · Sep 28, 2026
- Way Biosolutions, Inc. $2 million · Sep 25, 2026
- AutoIVF, Inc. $1.5 million · Sep 25, 2026
- Typewriter Therapeutics, Inc. $56.3 million · Sep 21, 2026
Every Form D from the week of Jan 28, 2019 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AGENUS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.